Home Cart Sign in  
Chemical Structure| 1531634-31-7 Chemical Structure| 1531634-31-7

Structure of AF38469
CAS No.: 1531634-31-7

Chemical Structure| 1531634-31-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AF38469 is an orally bioavailable inhibitor of the VPS10P family sorting receptor Sortilin with IC50 of 330 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AF38469

CAS No. :1531634-31-7
Formula : C15H11F3N2O3
M.W : 324.25
SMILES Code : O=C(NC1=CC=CC(C)=N1)C2=CC=C(C(F)(F)F)C=C2C(O)=O
MDL No. :MFCD28160694
InChI Key :JWCUSQCZMQIBMR-UHFFFAOYSA-N
Pubchem ID :72706115

Safety of AF38469

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U87 cells 400 nM 24 hours AF38469 significantly impaired the migratory capabilities of U87 and A172 cell lines. PMC6393543
A172 cells 400 nM 24 hours AF38469 significantly impaired the migratory capabilities of U87 and A172 cell lines. PMC6393543
MCF7 cells 10 μM 48 hours AF38469 effectively inhibited the progranulin-mediated maμMosphere-forming capacity of MCF7 cells. PMC6245804
MDA-MB 231 cells 10 μM 48 hours AF38469 effectively inhibited the progranulin-mediated maμMosphere-forming capacity of MDA-MB 231 cells. PMC6245804
Vero cells 0, 75, 150, 300, 500, 1000 nM 4 hours AF38469 inhibited T. gondii invasion and intracellular replication. PMC10910794
U87MG 400 nM 24 h After AF38469 treatment, U87MG cell invasion was reduced by 53%. PMC10177035
A172 400 nM 24 h After AF38469 treatment, A172 cell invasion was reduced by 53%. PMC10177035
BAH1 400 nM 72 h After AF38469 treatment, BAH1 cell invasion was reduced by 48%. PMC10177035
RKI1 400 nM 72 h After AF38469 treatment, RKI1 cell invasion was reduced by 38%. PMC10177035
PB1 400 nM 72 h After AF38469 treatment, PB1 cell invasion was reduced by 52%. PMC10177035

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Western diet-induced steatosis and hyperlipidemia model Oral 8 weeks AF38469 treatment significantly decreased plasma cholesterol levels, reduced hepatic VLDL secretion, and lowered hepatic pro-inflammatory cytokine expression. PMC6399493
Nude mice Subcutaneous and orthotopic glioblastoma models Intraperitoneal injection 100, 200, 400 mg 12 weeks AF38469 significantly decelerated the invasion growth of subcutaneous and orthotopic glioblastoma, and prolonged the survival time of tumor-bearing mice. PMC6393543
NOD SCID gamma mice Breast cancer xenograft model Drinking water 0.01 g/day/kg Once daily for 21 days AF38469 inhibited GRN A-induced breast cancer metastases and local infiltrative growth. PMC6245804
BALB/c mice T. gondii infection model Oral 10 mg/kg Once daily throughout the RISS procedure AF38469 prolonged the survival of mice infected with T. gondii. PMC10910794

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.42mL

3.08mL

1.54mL

30.84mL

6.17mL

3.08mL

References

 

Historical Records

Categories